Mbft 20logo 202
Mbft 20logo 202

MBF Therapeutics

Developing next generation Immunotherapeutics for infectious diseases and cancer for the animal and human health market using gene based check point inhibitors.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Ambler, PA, US
  • Currency USD
  • Founded June 2008
  • Employees 4
  • Incorporation Type C-corp
  • Website mbftherapeutics.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.